Pharmacogenomics in psychiatry - Clinical innovation utilised by the Therapeutic Goods Administration and Food and Drug Administration

Research output: Contribution to journalComment / DebateOtherpeer-review

Original languageEnglish
Pages (from-to)93-94
Number of pages2
JournalAustralian & New Zealand Journal of Psychiatry
Volume51
Issue number1
DOIs
Publication statusPublished - 1 Jan 2017

Cite this

@article{a88a35af67ac4a508f8aedb8dfa3a912,
title = "Pharmacogenomics in psychiatry - Clinical innovation utilised by the Therapeutic Goods Administration and Food and Drug Administration",
author = "Jayashri Kulkarni",
year = "2017",
month = "1",
day = "1",
doi = "10.1177/0004867416667233",
language = "English",
volume = "51",
pages = "93--94",
journal = "Australian & New Zealand Journal of Psychiatry",
issn = "0004-8674",
publisher = "SAGE Publications Ltd",
number = "1",

}

Pharmacogenomics in psychiatry - Clinical innovation utilised by the Therapeutic Goods Administration and Food and Drug Administration. / Kulkarni, Jayashri.

In: Australian & New Zealand Journal of Psychiatry, Vol. 51, No. 1, 01.01.2017, p. 93-94.

Research output: Contribution to journalComment / DebateOtherpeer-review

TY - JOUR

T1 - Pharmacogenomics in psychiatry - Clinical innovation utilised by the Therapeutic Goods Administration and Food and Drug Administration

AU - Kulkarni, Jayashri

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.scopus.com/inward/record.url?scp=85008721492&partnerID=8YFLogxK

U2 - 10.1177/0004867416667233

DO - 10.1177/0004867416667233

M3 - Comment / Debate

VL - 51

SP - 93

EP - 94

JO - Australian & New Zealand Journal of Psychiatry

JF - Australian & New Zealand Journal of Psychiatry

SN - 0004-8674

IS - 1

ER -